Dear nmusers,

I would like to model PK profiles of a compounds which mostly distributes in 
blood volume. The subjects which were investigated underwent hemodialysis for 
approx. the first three hours after infusion start, and the compound was given 
over a time period of ~5-10 min.
It is well known that during hemodialysis, blood volume changes. Therefore, I 
would like to add a dynamic component to the central volume parameter, allowing 
it to decrease during hemodialysis and then to reincrease after dialysis has 
ended. I have all information about start and end time of both dosing and 
dialysis. Individual times between subjects differed. Unfortunately, I have not 
been creative enough to come up with a NONMEM code that can do this. Could any 
of you help out?
Also, I probably do not have late enough time points to estimate when exactly 
blood volume would be restored. Does anyone know how much time the body needs 
after dialysis has ended until it is back to the original blood volume?

Thanks for your help and best
Nele
______________________________________________________________

Dr. Nele Käßner
Principal Scientist Modeling and Simulation
Global Pharmacometrics
Experimental Medicine

Takeda Pharmaceuticals International GmbH
Thurgauerstrasse 130
8152 Glattpark-Opfikon (Zürich)
Switzerland

Visitor address:
Alpenstrasse 3
8152 Glattpark-Opfikon (Zürich)
Switzerland

Phone: (+41) 44 / 55 51 404
Mobile: (+41) 79 / 654 33 99

mailto: [email protected]<mailto:[email protected]>
http://www.takeda.com


--------------------------------------------------------------------

The content of this email and of any files transmitted may contain 
confidential, proprietary or legally privileged information and is intended 
solely for the use of the person/s or entity/ies to whom it is addressed. If 
you have received this email in error you have no permission whatsoever to use, 
copy, disclose or forward all or any of its contents. Please immediately notify 
the sender and thereafter delete this email and any attachments.

--------------------------------------------------------------------

Reply via email to